Floatz logo

Palifermin

CLL (Chronic Lymphocytic Leukemia)

Center for International Blood and Marrow Transplant Researchprotein_peptidePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
81/ 100

Competitive context

11 Active assets in the CLL (Chronic Lymphocytic Leukemia) cohort.

Asset / SponsorPhaseRating
Ruxolitinib
Center for International Blood and Marrow Transplant Research
Phase 3BB
Lorazepam
Center for International Blood and Marrow Transplant Research
Phase 2CCC
HUMAN IMMUNOGLOBULINS
Center for International Blood and Marrow Transplant Research
Phase 2CCC
ABATACEPT RECOMBINANT
Center for International Blood and Marrow Transplant Research
Phase 2CCC
Ptcy
Center for International Blood and Marrow Transplant Research
Phase 2CCC

View all 10 →

Same molecule, other indications

Palifermin is also rated in:

mucositisDormant
BB
Indicative ·
64 / 100
View asset →
non-Hodgkin lymphomaDormant
B
Indicative ·
63 / 100
View asset →
plasma cell myelomaDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →